HIGHLIGHTS
- who: Rafieh Bagherifar from the (UNIVERSITY) have published the research: Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives, in the Journal: (JOURNAL)
- what: Considering the limitations of chemotherapy and immunotherapy, preclinical and clinical studies aim to enhance the anti-cancer efficacy by combining monotherapies .
- future: Potential of nanoparticles (NPs)-assisted CIT illustrates the promising way in which prospect of the CIT researches will be considered.
SUMMARY
Three forms of ACT, including tumor-infiltrating T lymphocyte (TIL), chimeric antigen receptor (CAR) T_cell, and engineered T_cell receptor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.